Thank you to our sponsors!

Alcom
Durysta
Ellex
Horizon
Harvest
Ivantis
Mallinckrodt
Ocular
Omeros
Regeneron

Find an Eye MD near you!

To evaluate the patient, disease, and tumor characteristics of the 3 morphologically distinct groups of vitreous seeds in retinoblastoma presenting for treatment with ophthalmic artery chemosurgery (OAC): dust (class 1), spheres (class 2), and clouds (class 3) in primary and recurrent vitreous seeds.

To determine the efficacy of topical 5-fluorouracil 1% (5-FU) as a primary treatment of ocular surface squamous neoplasia (OSSN).

To compare the 6-month efficacy and safety profile of an individualized stabilization criteria–driven pro re nata (PRN) regimen of ranibizumab 0.5 mg with or without laser versus laser alone in patients with visual impairment due to macular edema secondary to branch retinal vein occlusion (BRVO).

To determine the histologic and cellular correlates in the retina and retinal pigment epithelium (RPE) with the presence of optical coherence tomography-defined reticular pseudodrusen (RPD).

To evaluate the association between pseudodrusen and incidence of late age-related macular degeneration (AMD) in fellow eyes of patients with unilateral neovascular AMD (nAMD).

Twitter

Diagnose This: Minimizing ocular movement during phacoemulsification

◦Attention colleagues! Please reach out to your member of Congress regarding the rising drug prices and lack of tra… https://t.co/XKu7NezQAj

Looks like a great weekend for the WVAEPS 2018 Scientific Conference at the Greenbrier!!! Hope you made your regis… https://t.co/CNa5LLXj1t

Suffering eye strain at work? Follow these tips from the American Academy of Ophthalmology to get some relief. https://t.co/tfR8etzzG9